Yonsei University Health System

Running trials

• Recruiting

  A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

  NCT06149286· Phase 3· Source

• Active, not recruiting

  An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma

  NCT05876754· Phase 3· Source

• Recruiting

  A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

  NCT05118789· Phase 1/2· Source

• Not yet recruiting

  Long Term Evaluation and Management of Atrial Fibrillation in Pacemaker Patients

  NCT03401593· Source

• Active, not recruiting

  Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma

  NCT03681535· Source

• Recruiting

  Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

  NCT03564340· Phase 1/2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation1 recruiting
• Childhood cancers1 recruiting
• Endometrial cancer1 recruiting
• Follicular lymphoma1 recruiting
• Lung cancer1 recruiting
• Ovarian cancer1 recruiting
• Stroke1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration

  NCT05953012· Phase 1· Source

• Completed

  To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET Dysregulation

  NCT04052971· Phase 1· Source

• Completed

  PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer

  NCT02423603· Phase 2· Source

Trial sites

• Division of Cardiology, Yonsei University Health System, Yonsei University College of Medicine1 trial
• Yonsei University Health System7 trials
• Yonsei University Health System, Severance1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Lung cancer107 works · 2 trials
• Liver and biliary tract cancer98 works · 1 trial
• Gastric and esophageal cancer77 works · 0 trials
• Atrial fibrillation64 works · 1 trial
• Fatty liver disease (MASLD/MASH)52 works · 0 trials
• Parkinson disease49 works · 0 trials
• Ovarian cancer43 works · 1 trial
• Pancreatic cancer34 works · 0 trials
• Triple-negative breast cancer28 works · 1 trial
• Glioblastoma22 works · 0 trials
• Endometrial cancer20 works · 1 trial
• Migraine16 works · 0 trials
• Metastatic breast cancer13 works · 1 trial
• High blood pressure12 works · 0 trials
• Idiopathic pulmonary fibrosis11 works · 0 trials
• Thyroid cancer11 works · 0 trials
• ANCA-associated vasculitis10 works · 0 trials
• Myasthenia gravis7 works · 0 trials
• Lewy body dementia6 works · 0 trials